These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia. Knopman DS; Jack CR; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC Neurology; 2016 Aug; 87(7):691-8. PubMed ID: 27421543 [TBL] [Abstract][Full Text] [Related]
11. Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults. Berti V; Walters M; Sterling J; Quinn CG; Logue M; Andrews R; Matthews DC; Osorio RS; Pupi A; Vallabhajosula S; Isaacson RS; de Leon MJ; Mosconi L Neurology; 2018 May; 90(20):e1789-e1798. PubMed ID: 29653991 [TBL] [Abstract][Full Text] [Related]
12. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A; Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175 [TBL] [Abstract][Full Text] [Related]
13. Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study. Jack CR; Wiste HJ; Weigand SD; Rocca WA; Knopman DS; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Preboske GM; Pankratz VS; Vemuri P; Petersen RC Lancet Neurol; 2014 Oct; 13(10):997-1005. PubMed ID: 25201514 [TBL] [Abstract][Full Text] [Related]
14. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820 [TBL] [Abstract][Full Text] [Related]
15. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals. Wirth M; Madison CM; Rabinovici GD; Oh H; Landau SM; Jagust WJ J Neurosci; 2013 Mar; 33(13):5553-63. PubMed ID: 23536070 [TBL] [Abstract][Full Text] [Related]
17. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET. Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550 [TBL] [Abstract][Full Text] [Related]
18. Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals. Berti V; Murray J; Davies M; Spector N; Tsui WH; Li Y; Williams S; Pirraglia E; Vallabhajosula S; McHugh P; Pupi A; de Leon MJ; Mosconi L J Nutr Health Aging; 2015 Apr; 19(4):413-23. PubMed ID: 25809805 [TBL] [Abstract][Full Text] [Related]
19. Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area. Walters MJ; Sterling J; Quinn C; Ganzer C; Osorio RS; Andrews RD; Matthews DC; Vallabhajosula S; de Leon MJ; Isaacson RS; Mosconi L BMJ Open; 2018 Nov; 8(11):e023664. PubMed ID: 30478117 [TBL] [Abstract][Full Text] [Related]
20. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. Rostomian AH; Madison C; Rabinovici GD; Jagust WJ J Nucl Med; 2011 Feb; 52(2):173-9. PubMed ID: 21233181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]